Turniej Pokemon

xp075287

Acute mesenteric ischemia diagnosis

Chinese Journal of Ultrasonography, 2004,13 (6): 450. 【7】 Wuxiang De, Zhang Yongfeng. The diagnosis of mesenteric venous thrombosis and treatment 【J1. Chinese Traditional and Western Medicine. 2003, l5 (4): 5l2. Received: 2007 sucked for a l2 a o6 Ru Shuli Diego treatment of chronic obstructive pulmonary disease clinical observation of Li Jianrong, Li Ling (Wanzhou District People's Hospital. Wanzhou, Chongqing 404000, China) Abstract Objective: To observe the inhalation of Seretide ( salmeterol, fluticasone) in the treatment of a stable phase Ⅲ Ⅳ grade chronic obstructive pulmonary disease (COPD) the efficacy and safety. Methods: 48 patients in our hospital grade Ⅲ ~ Ⅳ stable COPD patients were randomly divided into two groups, control group: conventional therapy with conventional methods, namely,[link widoczny dla zalogowanych], oral theophylline, expectorant; experimental groups: the treatment on the basis of the traditional , plus Seretide inhalation. Period of 1 year to assess the two groups before and after testing lung function, dyspnea,[link widoczny dla zalogowanych], acute episodes and adverse reactions. Results: The course of treatment in 3 patients (2 patients in control group,[link widoczny dla zalogowanych], experimental group 1 patients) withdrew from the study due to lost,[link widoczny dla zalogowanych], the remaining 45 patients were completed the trial, the control group before the test, the experimental group forced expiratory volume in one second (FEV1), 1 second forced expiratory vital capacity accounts for the percentage of (FEV1, FVC) (%) and FEV1 percentage of predicted value percentage (%) difference was not statistically significant (0.05),[link widoczny dla zalogowanych], after the end of the experimental group and control group FEV1, FEV1, FVC FEV1 percentage of predicted value and the percentage (%) was significantly increased JJll (P <0.05), the control group showed no significant change before and after treatment (0.05), end of the treatment difference between the two groups above parameters were significantly (P < 0.05). Experimental group than in the control group, dyspnea was improved significantly fewer episodes of acute clinical symptom scores decreased significantly, the difference between the two groups was significant (P <0.05). A small number of the experimental group appeared throat discomfort, a brief palpitation, without treatment, go away, the patient can tolerate. Conclusion: The inhalation of Seretide treatment of stable COPD patients with grade Ⅲ ~ Ⅳ safe and effective. Key words Seretide; chronic obstructive pulmonary disease; stable Article ID: 10o9-5519 (2o08) 07-0985-03 CLC number in circle: R5 Document code: A chronic obstructive pulmonary disease (C0PD) is a common chronic respiratory disease, the sick population. High mortality. Seriously affect the ability to work and quality of life fl1. In recent years, with the progress of COPD ~ further in-depth research and new understanding of the pathogenesis and new emerging drugs, including long-term period B: receptor agonists, such as inhaled corticosteroids, especially the second combination therapy C0PD who is being more attention. Global Initiative for COPD in 2003 (GOLD) stage Ⅲ ~ Ⅳ recommended for COPD patients with repeated exacerbations and symptoms, in the long-acting inhaled B: receptor agonists can be based on the law of inhaled glucocorticoids. Application of our department agent Seretide treatment of dry powder inhalation in stable COPD patients with grade Ⅲ ~ Ⅳ achieved satisfactory results. Are reported as follows: 1 object and methods 1.1 Subjects: 48 patients were selected cases l1 March 2005 April 2006 l1 in my out-patient treatment of patients. Including 31 males and 17 females; age 46 to 78 years, mean 66.5 years old. According to history, physical examination, chest radiograph, pulmonary function and other tests, in line with the development of the 2003 edition GOLD diagnostic criteria. Stable clinical stage, severity of COPD cases of grade Ⅲ ~ Ⅳ. Nearly 1 year acute repeated 2 times. Before the test, 48d, when the long-acting bronchodilators stop, stop short-acting bronchodilator 24d, when. Exclusion criteria: (1) candidates used the first 2 weeks of systemic corticosteroids (intravenous, intramuscular, oral, etc.) are; (2) is B blocker; (3) p: receptor agonists history of allergies. 1.2 Treatment Methods: 48 patients were randomly divided into two groups, experimental group of 25 patients. 23 patients in control group between the two groups of height, weight, age, pulmonary function tests and other factors the difference was not statistically significant. Control group: conventional treatment to conventional, that is different oral theophylline 0.2, 1, 2 times. Ambroxol capsule 30nag. 3 times a day. Experimental group: In the routine treatment Jia Shuli Diego inhalation therapy (salmeterol and fluticasone 50 250g, GlaxoSmithKline), each time a suction, 2 times. Completion of each suction mouth water. 1.3 OUTCOME MEASURES: (1) before and after treatment measured forced expiratory volume in 1 second (FEV1), 1 second forced expiratory volume percentage vital capacity (FEV1, FVC) and FEV1 percentage of predicted value per
More articles related to topics：

timberland shoes Non- laser lacrimal lacrimal duct

UGG stivali Ibuprofen gel in the treatment of acut

tory burch outlet Empty follicle syndrome in 11 ca